Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Venus Medtech (Hangzhou) Inc. has announced its 2024 first class meeting of H share holders to consider and potentially approve several resolutions, including amendments to the company’s Articles of Association and general mandates for the repurchase of H shares. The meeting is scheduled for October 10, 2024, and the resolutions details are available in the company’s recent circular. Shareholders are advised to prepare for voting and proxy arrangements in advance of the meeting.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.